Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Long-term Depression01:05

Long-term Depression

33.7K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.7K
Long-term Depression01:03

Long-term Depression

3.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.6K
Cancer Survival Analysis01:21

Cancer Survival Analysis

827
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
827

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Layered Copper-Anthraquinone Coordination Polymer Cathode Leveraging Dual-Redox Sites and Facilitated Ion Diffusion for High-Performance Lithium-Ion Batteries.

Angewandte Chemie (International ed. in English)·2026
Same author

Spatially Resolved Proteomic Cartography Illuminates the Earliest Molecular Programs in Pancreatic Cancer Evolution.

Cancer discovery·2026
Same author

Quantitative optimisation of indocyanine green fluorescence for parathyroid imaging in robotic BABA thyroidectomy: a prospective cohort study.

Surgical endoscopy·2026
Same author

Charting human cellular senescence in aging and disease.

Cell·2026
Same author

Large-scale, spatially resolved panoramic CRISPR screening in native tissue environments using Perturb-DBiT.

Nature biotechnology·2026
Same author

Integrating the Ki67 proliferation index into risk-adapted management of medullary thyroid carcinoma: evidence from the first large retrospective chinese cohort.

Endocrine·2026
Same journal

EEG Functional Connectivity Associated With Antidepressant Response to Transcutaneous Electrical Cranial-Auricular Acupoint Stimulation.

CNS neuroscience & therapeutics·2026
Same journal

Cingulate Gradient Dysfunction in End-Stage Renal Disease: Associations With Clinical Phenotypes and Exploratory Transcriptomic Signatures.

CNS neuroscience & therapeutics·2026
Same journal

Dual Antiplatelet Therapy in Acute Branch Atheromatous Disease (BAD)-Related Stroke: A Multicenter Propensity-Matched Cohort Analysis.

CNS neuroscience & therapeutics·2026
Same journal

Postherpetic Neuralgia: Mechanisms, Risk Factors, and Stratified Management-A Narrative Review.

CNS neuroscience & therapeutics·2026
Same journal

FAST BEE (Keeping FAST First): A Public Stroke Education Design to Drive EMS Activation.

CNS neuroscience & therapeutics·2026
Same journal

Conventional MRI-Based Semantic Features for Differentiation of Pediatric Medulloblastoma and Ependymoma in the Fourth Ventricle: Insights From a Multi-Center Retrospective Study.

CNS neuroscience & therapeutics·2026
See all related articles

Related Experiment Video

Updated: Mar 29, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.5K

Predicting Long-Term Depression Progression in Parkinson's Disease: A Machine-Learning Survival Analysis and Risk

Defu Liu1,2, Chong Qi3, Jiansong Huang1

  • 1Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

CNS Neuroscience & Therapeutics
|March 28, 2026
PubMed
Summary
This summary is machine-generated.

Predicting depression progression in Parkinson's disease (PD) is crucial. A new machine learning model effectively identifies individuals at high risk, enabling personalized management strategies for better quality of life.

Keywords:
Parkinson's diseasedepressionmachine learningrisk stratificationsurvival analysis

More Related Videos

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.7K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.5K

Related Experiment Videos

Last Updated: Mar 29, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.5K
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.7K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.5K

Area of Science:

  • Neuroscience
  • Medical Informatics
  • Biostatistics

Background:

  • Depression in Parkinson's disease (dPD) is a prevalent and heterogeneous condition that significantly impacts patient quality of life and may accelerate disease progression.
  • Current tools for predicting long-term dPD progression are lacking, highlighting a critical unmet need in clinical management.

Purpose of the Study:

  • To develop and validate a predictive model for long-term depressive progression in de novo, drug-naïve Parkinson's disease (PD) patients.
  • To identify key demographic, motor, and non-motor predictors of dPD progression.
  • To create an accessible risk score for pragmatic clinical stratification.

Main Methods:

  • Retrospective analysis of de novo, drug-naïve PD participants from the Parkinson's Progression Markers Initiative (PPMI).
  • Utilized four survival machine learning models (RSF, XGBoost, SVM, GBS) to predict depressive progression (sustained GDS-15 worsening).
  • Employed Shapley Additive exPlanations (SHAP) for predictor identification and risk score construction.

Main Results:

  • The Random Survival Forest (RSF) model demonstrated the best predictive performance (test-set C-index 0.744).
  • Key predictors included baseline GDS-15, age, SCOPA-AUT subscores, cognitive function (BJLOT, SDMT), impulse control disorder (QUIP-CS), and MDS-UPDRS I.
  • The SHAP-derived risk score successfully stratified patients into low, moderate, and high-risk groups with significant Kaplan-Meier separation (log-rank p < 0.001).

Conclusions:

  • An explainable survival model and an integer-based risk score were developed using routinely collected measures.
  • This tool accurately predicts long-term dPD progression.
  • The model enables pragmatic risk stratification to support early, personalized management of dPD.